Steven Isakoff

11 posts

Steven Isakoff

@steveisakoff

Katılım Aralık 2015

106 Takip Edilen77 Takipçiler

Steven Isakoff@steveisakoff·16 Ara

Congratulations to friend and colleague Dr Aditya Bardia @dradityabardia on your new position! We will miss you tremendously at @MGHCancerCenter and @MGHBreastOnc but look forward to all the great things you will accomplish at UCLA. They are lucky to have you.

.@UCLAJCCC

We're proud to announce internationally renowned oncologist and pioneering cancer researcher Dr. Aditya Bardia has joined @UCLAJCCC to lead the breast cancer program and translational research integration at UCLA Health. bit.ly/3tiTgVE

English

Steven Isakoff@steveisakoff·5 Haz

Excellent presentation by @BarYaelMD form @MGHBreastOnc showing that the more you biopsy in tnbc the more likely the chance of her2 low result. Likely analytic variation, but opens access to TDXd.

English

843

Steven Isakoff@steveisakoff·14 Ara

Congratulations to our amazing colleague! Excited to see all that you will accomplish moving the Mass General Cancer Center onward and upward!

MGBCI Breast Oncology@MGBCI_BreastOnc

Congratulations to Dr. Laura Spring @MGHBreastOnc who has been named Network Clinical Director for Integrated Sites @MGHCancerCenter! We look forward to Dr. Spring’s leadership as we continue to integrate state-of-the-art care and research throughout our network #WomenLeaders

English

Steven Isakoff retweetledi

MGBCI Breast Oncology@MGBCI_BreastOnc·5 Ara

Excited to launch a Twitter account for the Breast Oncology Program @MGHCancerCenter! We're a team dedicated to providing compassionate, multidisciplinary, patient-centered care #breastcancer #bcsm Learn more here: massgeneral.org/cancer-center/…

English

Steven Isakoff@steveisakoff·2 Haz

@ErikaHamilton9 @drsarahsam Until we have better drugs for TNBC brain mets, maybe time to take a second look at this study with PCI: pubmed.ncbi.nlm.nih.gov/25976296/

English

Erika Hamilton, MD, FASCO@ErikaHamilton9·31 May

@drsarahsam Wow! Now if it was #HER2 we'd have a trial with tucatinib designed in a second. #TNBC....hmmm.

English

Steven Isakoff retweetledi

FDA Oncology@FDAOncology·27 Nis

#FDAODAC votes 7 to 2 in favor of maintaining the indication for atezolizumab in combination w/nab-paclitaxel for patients with unresectable locally advanced or metastatic TNBC whose tumors are PD-L1+ while additional trial(s) are completed.

English

Steven Isakoff@steveisakoff·9 Şub

Fascinating FDA ODAC meeting re Keynote522 data. Informative presentations of the data and a good example for those interested in seeing how FDA approaches these questions.

Harold J. Burstein, MD, PhD, FASCO@DrHBurstein

On question of pembro + chemo as neoadj therapy for TNBC, @FDAOncology ODAC advisory committee votes 10-0 to recommend deferring FDA decision until longer follow-up. @OncoAlert

English

Steven Isakoff retweetledi

Harold J. Burstein, MD, PhD, FASCO@DrHBurstein·9 Şub

On question of pembro + chemo as neoadj therapy for TNBC, @FDAOncology ODAC advisory committee votes 10-0 to recommend deferring FDA decision until longer follow-up. @OncoAlert

English

Steven Isakoff retweetledi

Nancy Lin, MD@nlinmd·9 Ara

Globally, 17 million people receive a new cancer diagnosis each year. Millions of cancer survivors. Note the exclusion criteria of COVID vaccine trials. @tmprowell @DrChoueiri

English

181

Steven Isakoff@steveisakoff·7 Nis

Intrigued by this trial for healthcare workers, especially as I plan to help on our COVID service in the coming weeks.

English

Steven Isakoff@steveisakoff·7 Nis

Noopur and Jag - hope you are feeling better and thanks for sharing your story. #StayMiGHty

Noopur Raje@NoopurRajeMD

1/I never tweet about personal issues—but this is way too important—I am COVID positive and asymptomatic and have been a caregiver for my husband @JagSinghMD who was critically ill with #COVID19. I've learned some things - please follow for more 1/25

English

Keşfet

@dradityabardia @BarYaelMD @ErikaHamilton9 @drsarahsam @FDAOncology @OncoAlert @tmprowell @DrChoueiri